Myriad Genetics, Inc.MYGNNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank93
3Y CAGR+5.1%
5Y CAGR+1.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+5.1%/yr
vs -1.0%/yr prior
5Y CAGR
+1.8%/yr
Recent acceleration
Acceleration
+6.1pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $715.90M | +1.0% |
| 2024 | $708.90M | -8.5% |
| 2023 | $774.40M | +25.5% |
| 2022 | $617.00M | -9.7% |
| 2021 | $683.50M | +4.6% |
| 2020 | $653.30M | -4.5% |
| 2019 | $684.20M | +6.5% |
| 2018 | $642.50M | +19.4% |
| 2017 | $537.90M | -2.3% |
| 2016 | $550.80M | - |